Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

SNOAW - Sonoma Pharmaceuticals Inc. Warrant 2016-21.01.20 on Sonoma Pharmaceuticals

Previous close
0.002
0   0%

Share volume: 0
Last Updated: Wed 22 Jan 2020 06:00:00 AM CET
Pharmaceuticals: Other: 0%

PREVIOUS CLOSE
CHG
CHG%
$0.00
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
62%
Profitability 75%
Dept financing 25%
Liquidity 18%
Performance 70%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$0.00
P/E Ratio 
N/A
DAY RANGE
$0.00 - $0.00
EPS 
$0.00
52 WEEK RANGE
$0.01 - $0.45
52 WEEK CHANGE
-$93.33
MARKET CAP 
31.995 K
YIELD 
N/A
SHARES OUTSTANDING 
1.330 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$124,790
AVERAGE 30 VOLUME 
$56,751
Company detail
CEO: Amy M. Trombly
Region: US
Website: http://www.sonomapharma.com
Employees: 0
IPO year: -
Issue type:
Market: NASDAQ
Industry: Pharmaceuticals: Other
Sector: Health Technology

Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. The company offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Petaluma, CA.

Recent news